Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 235 of 1,261
  1. US 11464856

    Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  2. US 11464737

    Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  3. US 11466015

    Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  4. US 11464801

    Compositions and methods for treating cancer with anti-CD33 immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  5. CA 3215723

    PROCEDES DE DIAGNOSTIC DU CANCER DE LA PROSTATE

    ADVANCED ACCELERATOR APPLICATIONS [FR] · Granted Oct 6, 2022 · Expires Oct 1, 2042

    granted
  6. CA 3213326

    METHODES ET COMPOSITIONS POUR AMELIORER LA PRODUCTION ET LA SECRETION D'INSULINE

    ABBOTT LAB [US] · Granted Oct 6, 2022 · Expires Oct 1, 2042

    granted
  7. US 11459320

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  8. US 11459340

    Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  9. US 11459373

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  10. US 11459335

    N/O-linked Degrons and Degronimers for protein degradation

    C4 THERAPEUTICS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  11. US 11458210

    Compounds and compositions for targeting brain injuries and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  12. US 11459298

    Class of dicationic compounds as well as the preparative method and the use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  13. US 11459300

    Deuterated compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  14. US 11459323

    Monocyclic β-lactam compound for treating bacterial infection

    Medshine Discovery Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  15. US 11458174

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  16. US 11459325

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  17. US 11459374

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  18. US 11458143

    Method of treatment of attention deficit/hyperactivity disorder (ADHD)

    Supernus Pharmaceuticals, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  19. US 11458116

    Method of improving sleep

    VANDA PHARMACEUTICALS INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  20. US 11458136

    Antiviral prodrugs and formulations thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  21. US 11458154

    Treatment of CYR61- and VEGF-mediated conditions

    VANDA PHARMACEUTICALS INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  22. US 11458094

    Compositions and methods for treating pulmonary edema or lung inflammation

    Regents of the University of Minnesota · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  23. US 11458171

    Engineering stem cells for cancer therapy

    China Medical University · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  24. US 11458173

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.